Trending...
- Spiritually Transformative Events Based on Bhagavad Gita – Path to a Fulfilling Life
- Author Deric Whaley's book 'The Ride' gives unique insider view on prison life
- Enable Accessible Haircare Wins Bronze at 2025 NACD Packaging Awards
The platform launches with over 8,000 brands, supporting five languages and helping users worldwide share and discover referral codes with ease.
ROME - illiNews -- ReferFriends.io, a brand-new platform dedicated to sharing and discovering referral codes, invite links, and "refer-a-friend" deals, has officially launched, aiming to revolutionize the way people benefit from brand promotions worldwide.
At launch, ReferFriends.io offers an impressive database of over 8,000 global brands—from leading tech services and streaming platforms to e-commerce and travel companies. Users can easily search and share referral codes, helping each other save money and unlock exclusive rewards.
The platform is available in five languages—English, German, Spanish, French, and Italian—making it accessible to users across various regions. One of its standout features is the geo-validation tool, which allows users to check whether a referral code or invite link is valid in their specific country before using it.
More on illi News
"Referral programs are everywhere, but they're scattered and often underused. We wanted to build a space where people can easily find and share these opportunities in a transparent, community-driven way," said the ReferFriends.io team.
Key Features:
An exciting second release is already in the pipeline, which will introduce a priority listing feature, allowing users to promote their referral codes or invite links for increased visibility.
ReferFriends.io is now live and ready to build a global community around sharing and saving. Visit https://www.referfriends.io to explore, contribute, and benefit.
For more information, please contact:
info@referfriends.io
https://www.referfriends.io
At launch, ReferFriends.io offers an impressive database of over 8,000 global brands—from leading tech services and streaming platforms to e-commerce and travel companies. Users can easily search and share referral codes, helping each other save money and unlock exclusive rewards.
The platform is available in five languages—English, German, Spanish, French, and Italian—making it accessible to users across various regions. One of its standout features is the geo-validation tool, which allows users to check whether a referral code or invite link is valid in their specific country before using it.
More on illi News
- Tomorrow's World Today Shines Bright with Four Telly Awards at the 46th Annual Telly Awards
- AbbVie Partners with Chicago Cubs on "Striking Out Cancer"
- Chicago: Mayor Brandon Johnson, City Officials, Lamar Johnson Collaborative, and 548 Development Attend Groundbreaking of Mixed-Use West Humboldt Park Development
- ILLINOIS TEAMSTERS DEMAND LAWMAKERS PREVENT CATASTROPHIC CUTS TO PUBLIC TRANSPORTATION
- 6 Love Sports and Eight Sleep Announce Partnership Miami Women's Padel League Rebranded as the Eight Sleep Miami Women's Padel League by 6 Love Sports
"Referral programs are everywhere, but they're scattered and often underused. We wanted to build a space where people can easily find and share these opportunities in a transparent, community-driven way," said the ReferFriends.io team.
Key Features:
- A curated database of 8,000+ global brands with active referral programs
- Multi-language interface (EN, DE, ES, FR, IT)
- Country-specific code validation
- User reviews and ratings for each code—helping others know what works
- Private messaging system for direct interaction between users
- Smart filters to browse brands by product category or country of origin
- Email-based technical support to assist with any user queries
An exciting second release is already in the pipeline, which will introduce a priority listing feature, allowing users to promote their referral codes or invite links for increased visibility.
ReferFriends.io is now live and ready to build a global community around sharing and saving. Visit https://www.referfriends.io to explore, contribute, and benefit.
For more information, please contact:
info@referfriends.io
https://www.referfriends.io
Source: Bloo Srl
0 Comments
Latest on illi News
- Chosen Launches Mobile Family Closet to Serve Foster, Adoptive, and Kinship Families Across Southeastern Wisconsin
- New Release Explores Grit, Wit, and Appalachian Life in We Saved Ourselves, Kinda
- WNC Roofing, LLC Opens Spartanburg, SC Location After a Decade of Serving the Upstate
- June Is Men's Health Month 2025:
- Velocity Performance Alliance Shifts Into High Gear with Luxury Auto Real Estate Platform Ahead of NASCAR Debut
- Floating Water Ramp for Pups is Still Making a Splash
- Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
- UIFCA Wealth Academy's Revolutionary UIFCA(UFCA) Token Gains Momentum in AI-Powered Investment Market
- Naperville Offering Two New Recycling Programs Starting June 2
- New Website Launch Positions TekTone Builders As Tulsa's Commercial Construction Leader
- Inframark Expands Its Capabilities and Presence in Arizona, Adding Wastewater Experts Mehall Contracting
- FilmHedge Is Letting A.I. Into the Deal Room—And Hollywood Will Never Be the Same
- The Inner Circle acknowledges, Dr. Rashid G. Mosley as a Pinnacle Professional Member
- Naperville: Cook County Convicted Felon Charged with Alleged Illegal Possession of Four Loaded Firearms
- This Artificial Intelligence Platform Could Change How Hollywood Gets Funded Forever
- Chicago: Mayor Johnson Announces $20 Million in Grant Awards for Community Development Projects
- $100 Million Financing Unlocked for Aggressive Acquisition and Growth Strategy Including Plan to Acquire Remote Lottery Platform: Stock Symbol: LTRY
- ARCH Dental + Aesthetics Unveils New Website for Enhanced Patient Experience
- GO2 Partners Named to PPAI 100 List
- Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies